CDP vs DOC
COPT Defense Properties vs Healthpeak Properties — AI-powered side-by-side comparison
CDP
COPT Defense Properties
65
Insufficient Data
VS
DOC
Healthpeak Properties
64
Buy
| Metric | CDP | DOC |
|---|
| AI Score |
65
|
64
|
| Price |
$36.38
|
$20.50
|
| P/E Ratio |
25.10×
|
58.60×
|
| ROE |
10.1%
|
1.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
37.6%
|
2.5%
|
| Debt / Equity |
1.75×
|
1.32×
|
| Dividend Yield |
3.4%
|
5.9%
|
| RSI (14) |
27.4
|
31.1
|
| Beta |
0.789
|
0.991
|
| Expected Upside |
—
|
+1.6%
|
AI Committee View
Current Innellis committee reasoning for CDP versus DOC.
CDP leads by 1 points.
CDP scores 65/100 (Insufficient Data) versus DOC at 64/100 (Buy).
CDP Committee View
67% agreement
3 analysts
Some positive signals exist — vix regime is low -- calm backdrop supports risk-taking — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- RSI at 27 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
- MACD histogram negative -- bearish momentum — Technical
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical